Exploring Biomarkers to Predict the Response to Immunotherapy-Based Combination Treatment in Hepatocellular Carcinoma Using Epiontis ID™ Reza Sedaghat2022-10-06T10:33:50-04:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-Associated Mechanisms of Action Carlos Bonilla2022-08-08T17:01:39-04:00Resources| Read More
Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg Carlos Bonilla2022-08-08T17:03:52-04:00Resources| Read More
Circulating Immune Cell Composition and Cancer Risk: A Prospective Study Using Epigenetic Cell Count Measures Carlos Bonilla2022-08-08T17:04:09-04:00Resources| Read More
The Cellular Ratio of Immune Tolerance (immunoCRIT) Is a Definite Marker for Aggressiveness of Solid Tumors and May Explain Tumor Dissemination Patterns Carlos Bonilla2022-08-08T17:07:53-04:00Resources| Read More
Epigenetic Quantification of Tumor-Infiltrating T-Lymphocytes Carlos Bonilla2022-08-08T17:08:18-04:00Resources| Read More
Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy Carlos Bonilla2022-08-08T17:11:33-04:00Resources| Read More
Regulatory T Cells Are Not a Strong Predictor of Survival For Patients With Glioblastoma Carlos Bonilla2022-08-19T16:21:05-04:00Resources| Read More
